Search research articles
Contact Us
Filters
Showing results (881-890 of 931) with videos related to
Page
of 94
Sort By:
Vaccine: X
|
June 13, 2020
Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein
Juilee Thakar, Yu Qian, Lauren Benoodt, et al.
Plos Computational Biology
|
December 28, 2021
A systems genomics approach uncovers molecular associates of RSV severity
Matthew N McCall, Chin-Yi Chu, Lu Wang, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
<i>APOE4</i> drives transcriptional heterogeneity and maladaptive immunometabolic responses of astrocytes
Sangderk Lee, Holden C Williams, Amy A Gorman, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
May 23, 2019
Use of EHR-Based Pediatric Quality Measures: Views of Health System Leaders and Parents
David M Hartley, Susannah Jonas, Daniel Grossoehme, et al.
The Journal of Infectious Diseases
|
September 14, 2020
Airway Gene Expression Correlates of Respiratory Syncytial Virus Disease Severity and Microbiome Composition in Infants
Chin-Yi Chu, Xing Qiu, Matthew N McCall, et al.
Plos One
|
April 13, 2016
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus
Sarah V Maifeld, Bodrey Ro, Hoyin Mok, et al.
Journal of Medical Genetics
|
March 29, 2011
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis
Fanny Kortüm, Soma Das, Max Flindt, et al.
The Journal of Infectious Diseases
|
October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals
Ann R Falsey, Edward E Walsh, Jose Capellan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 10, 2025
Efficacy, Immunogenicity, and Safety of the Bivalent RSV Prefusion F (RSVpreF) Vaccine in Older Adults Over 2 RSV Seasons
Edward E Walsh, Daniel Eiras, John Woodside, et al.
Aging Cell
|
May 31, 2017
Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle health
Ning Zhang, Joseph M Valentine, You Zhou, et al.
Page
of 94
Search research articles
Search
Showing results (881-890 of 931) with videos related to
Sort By:
Page
of 94
Vaccine: X
|
June 13, 2020
Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein
Juilee Thakar, Yu Qian, Lauren Benoodt, et al.
Plos Computational Biology
|
December 28, 2021
A systems genomics approach uncovers molecular associates of RSV severity
Matthew N McCall, Chin-Yi Chu, Lu Wang, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
<i>APOE4</i> drives transcriptional heterogeneity and maladaptive immunometabolic responses of astrocytes
Sangderk Lee, Holden C Williams, Amy A Gorman, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
May 23, 2019
Use of EHR-Based Pediatric Quality Measures: Views of Health System Leaders and Parents
David M Hartley, Susannah Jonas, Daniel Grossoehme, et al.
The Journal of Infectious Diseases
|
September 14, 2020
Airway Gene Expression Correlates of Respiratory Syncytial Virus Disease Severity and Microbiome Composition in Infants
Chin-Yi Chu, Xing Qiu, Matthew N McCall, et al.
Plos One
|
April 13, 2016
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus
Sarah V Maifeld, Bodrey Ro, Hoyin Mok, et al.
Journal of Medical Genetics
|
March 29, 2011
The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis
Fanny Kortüm, Soma Das, Max Flindt, et al.
The Journal of Infectious Diseases
|
October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals
Ann R Falsey, Edward E Walsh, Jose Capellan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 10, 2025
Efficacy, Immunogenicity, and Safety of the Bivalent RSV Prefusion F (RSVpreF) Vaccine in Older Adults Over 2 RSV Seasons
Edward E Walsh, Daniel Eiras, John Woodside, et al.
Aging Cell
|
May 31, 2017
Sustained NFκB inhibition improves insulin sensitivity but is detrimental to muscle health
Ning Zhang, Joseph M Valentine, You Zhou, et al.
Page
of 94